摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-hydroxy-4-methoxybenzylidene)cyclopentanone

中文名称
——
中文别名
——
英文名称
2-(3-hydroxy-4-methoxybenzylidene)cyclopentanone
英文别名
2-[(3-hydroxy-4-methoxyphenyl)methylidene]cyclopentan-1-one
2-(3-hydroxy-4-methoxybenzylidene)cyclopentanone化学式
CAS
——
化学式
C13H14O3
mdl
——
分子量
218.252
InChiKey
NYHYZZCESUCGDU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(3-hydroxy-4-methoxybenzylidene)cyclopentanone乙腈 为溶剂, 反应 14.0h, 生成 2-methylene-5-(3-hydroxy-4-methoxybenzylidene)cyclopentanone
    参考文献:
    名称:
    2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF
    摘要:
    本发明涉及2-亚甲基-5-取代-亚甲基环戊酮衍生物,其具有公式I的结构,以及这些衍生物的用途。公式I的衍生物作为活性成分,可用于制备治疗和/或预防诸如乳腺癌、肺癌、结肠癌、直肠癌、胃癌、前列腺癌、膀胱癌、子宫癌、胰腺癌和卵巢癌等癌症疾病的药物。本发明的活性化合物可以单独用作抗癌药物,或与一个或多个其他抗肿瘤药物联合使用。可以通过同时、随后或分别给药每个治疗成分来进行联合治疗。
    公开号:
    US20110060054A1
  • 作为产物:
    描述:
    环戊酮盐酸对甲苯磺酸 作用下, 以 乙醇环己烷 为溶剂, 反应 8.5h, 生成 2-(3-hydroxy-4-methoxybenzylidene)cyclopentanone
    参考文献:
    名称:
    含有邻甲氧基苯基的环状 C7 桥联单羰基姜黄素类似物作为潜在抗胃癌药物的设计、合成和评估
    摘要:
    C7 桥接单羰基姜黄素类似物 (MCA) 的毒性与连接酮类型之间的构效关系 (SAR) 尚不清楚。为了追求有效和少...
    DOI:
    10.1080/14756366.2024.2314233
点击查看最新优质反应信息

文献信息

  • 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof
    申请人:Zhao Linxiang
    公开号:US08415505B2
    公开(公告)日:2013-04-09
    The invention relates to 2-methylene-5-substituted-methylenecyclopentanone derivatives of formula I, and the use thereof. The derivatives of formula I as active components are useful for preparing a medicine for the treatment and/or prevention of cancer diseases such as breast cancer, lung cancer, colon cancer, rectal cancer, stomach cancer, prostate cancer, bladder cancer, uterus cancer, pancreatic cancer and ovary cancer. The active compounds of the invention may be used as an anticancer drug alone or used in combination with one or more other antitumor drugs. A combined therapy can be carried out by administrating each therapeutic component concurrently, subsequently or separately.
    本发明涉及公式I的2-亚甲基-5-取代亚甲基环戊酮衍生物及其用途。公式I的衍生物作为活性成分,可用于制备用于治疗和/或预防癌症疾病,如乳腺癌、肺癌、结肠癌、直肠癌、胃癌、前列腺癌、膀胱癌、子宫癌、胰腺癌和卵巢癌的药物。本发明的活性化合物可单独用作抗癌药物,也可与一种或多种其他抗肿瘤药物联合使用。联合治疗可以通过同时、随后或分别给予每种治疗成分来进行。
  • EP2248796
    申请人:——
    公开号:——
    公开(公告)日:——
  • 2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF
    申请人:Zhao Linxiang
    公开号:US20110060054A1
    公开(公告)日:2011-03-10
    The invention relates to 2-methylene-5-substituted-methylenecyclopentanone derivatives of formula I, and the use thereof. The derivatives of formula I as active components are useful for preparing a medicine for the treatment and/or prevention of cancer diseases such as breast cancer, lung cancer, colon cancer, rectal cancer, stomach cancer, prostate cancer, bladder cancer, uterus cancer, pancreatic cancer and ovary cancer. The active compounds of the invention may be used as an anticancer drug alone or used in combination with one or more other antitumor drugs. A combined therapy can be carried out by administrating each therapeutic component concurrently, subsequently or separately.
    本发明涉及2-亚甲基-5-取代-亚甲基环戊酮衍生物,其具有公式I的结构,以及这些衍生物的用途。公式I的衍生物作为活性成分,可用于制备治疗和/或预防诸如乳腺癌、肺癌、结肠癌、直肠癌、胃癌、前列腺癌、膀胱癌、子宫癌、胰腺癌和卵巢癌等癌症疾病的药物。本发明的活性化合物可以单独用作抗癌药物,或与一个或多个其他抗肿瘤药物联合使用。可以通过同时、随后或分别给药每个治疗成分来进行联合治疗。
  • Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an <i>o</i> -methoxy phenyl group as potential agents against gastric cancer
    作者:Xin Gan、Yuna Wu、Min Zhu、Bo Liu、Miaomiao Kong、Zixuan Xi、Ke Li、Haibao Wang、Tiande Su、Jiali Yao、Fatehi Khushafah、Baozhu Yi、Jiabing Wang、Wulan Li、Jianzhang Wu
    DOI:10.1080/14756366.2024.2314233
    日期:2024.12.31
    The structure-activity relationship (SAR) between toxicity and the types of linking ketones of C7 bridged monocarbonyl curcumin analogs (MCAs) was not clear yet. In the pursuit of effective and les...
    C7 桥接单羰基姜黄素类似物 (MCA) 的毒性与连接酮类型之间的构效关系 (SAR) 尚不清楚。为了追求有效和少...
查看更多